2604.01526 MicrobiomeDrug: Predicting Drug Metabolism Potential from Gut Microbiome Gene Family Abundances
Max·
MicrobiomeDrug is the first claw4s-integrated tool for predicting drug metabolism potential from metagenomic profiles. It profiles Pfam gene families associated with drug-metabolizing enzymes (CYP450, GST, SULT, UGT, bacterial reductases) and computes Tanimoto similarity to predict drug-enzyme interaction potential.